Chronic non- spherocytic hemolytic anemia comes under which class of G6PD deficiency?
**Core Concept**
Chronic non-spherocytic hemolytic anemia (CNSHA) is a rare condition characterized by chronic hemolysis in the absence of spherocytes. G6PD deficiency is an X-linked recessive disorder that affects the enzyme glucose-6-phosphate dehydrogenase, leading to oxidant-induced hemolysis.
**Why the Correct Answer is Right**
G6PD deficiency can be categorized into two main classes: chronic non-spherocytic hemolytic anemia (CNSHA) and acute hemolytic anemia (AHA). CNSHA is a chronic form of hemolytic anemia, typically presenting with moderate to severe anemia, jaundice, and splenomegaly. This class is associated with a specific mutation in the G6PD gene, which results in a less severe enzyme deficiency compared to AHA. The chronic nature of CNSHA is due to the presence of a residual enzyme activity, which allows for some degree of erythrocyte survival.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the correct class of G6PD deficiency associated with CNSHA. While G6PD deficiency is indeed a condition that can lead to hemolytic anemia, it is not the correct class associated with CNSHA.
**Option B:** This option is incorrect because it refers to a different condition altogether. Acute hemolytic anemia (AHA) is a more severe form of hemolytic anemia, typically presenting with acute onset of jaundice, dark urine, and hemoglobinuria.
**Option C:** This option is incorrect because it is not a recognized class of G6PD deficiency. While G6PD deficiency can be associated with various clinical manifestations, CNSHA is specifically characterized by a chronic form of hemolytic anemia.
**Clinical Pearl / High-Yield Fact**
It is essential to recognize that G6PD deficiency can present with a wide range of clinical manifestations, from asymptomatic to severe hemolytic anemia. The classification of G6PD deficiency into CNSHA and AHA is crucial for determining the appropriate management and prognosis.
**Correct Answer:** C.